MOH to list promoted treatment for over 100 disease categories

The MOH further announced plans to release a list of over 100 disease categories that will be covered by the clinical pathway management system and to promote the system in all level three hospitals nationwide. The clinical pathway system may be an important...

Novo Nordisk to expand Beijing R&D center

Novo Nordisk revealed last week that its recently-announced Beijing (diabetes) R&D center expansion has a budget of USD 100 million – with up to USD 40 million earmarked for new labs that should be operational by the end of 2011. Novo also released results...